Glycogenosis IV: A new cause of infantile hypotonia

Zellweger, H; Mueller, Shirley M.; Ionâşescu, Victor; Schochet, Sydney S.; McCormick, William F.

doi:10.1016/s0022-3476(72)80144-6

Cited by 54 publications

(34 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The liver is usually the earliest casualty, but there can be an array of clinical presentations depending on the dominant organ system affected. Occasional cases of presenting cardiomyopathy [5,12,14,27], neurological syndromes [9,21] or musculoskeletal manifestations [11,12,35] have been reported. In these unusual patients, the clinical onset frequently is later than in the typical case of type IV disease, and death most often results from myocardial causes.…”

Section: Discussionmentioning

confidence: 99%

“…Fatal hepatic complications usually occur by the age of 2-4 years, but in exceptional cases involvement in other organ systems may be prominent mortality factors [4,5,12,14,27,35]. Liver transplantation for this disease was first attempted in 1972, but the recipient died 110 days later after uncontrolled rejection of his first liver and attempted retransplantation [31].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Liver transplantation for type I and type IV glycogen storage disease

et al. 1993

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Liver transplantation for type I and type IV glycogen storage disease

et al. 1993

View full text Add to dashboard Cite

“…The usual clinical consequence is fatal cirrhosis within 1 or 2 yr after birth However, patients who do not die from liver disease are subject to lethal cardiomyopathy or neuromuscular syndromes (52)(53)(54)(55). Because the enzyme deficiency and consequent amylopectin deposition affect all cells, not just those in the liver, it was surprising to many experts in metabolism when absorption occurred of the amylopectin from the heart and other extrahepatic tissues of five patients with GSD IV 1.3 to 6 yr after liver replacement ( Fig.…”

Section: Direct Evidence Of Systemicmentioning

confidence: 99%

Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance

et al. 1993

View full text Add to dashboard Cite

Improvements in the prevention or control of rejection of the kidney and liver have been largely interchangeable (1,2) and then applicable, with very little modification, to thoracic and other organs. However, the mechanism by which anti rejection treatment permits any of these grafts to be "accepted" has been an immunological enigma (3,4). We have proposed recently that the exchange of migratory leukocytes between the transplant and the recipient with consequent long-term cellular chimerism in both is the basis for acceptance of all whole-organ allografts and xenografts (5). Although such chimerism was demonstrated only a few months ago, the observations have increased our insight into transplantation immunology and have encouraged the development of alternative therapeutic strategies (6). DISCOVERY OF GRAFT CHIMERISM After Liver TransplantationSuccessful transplants were long envisioned as an alien patch in a homogeneous host (Fig. 1, left). The first unequivocal evidence that whole-organ grafts in human beings become genetic composites (chimeras) was obtained in 1969 with karyotyping studies in female recipients of livers obtained from male cadaveric donors. Postoperatively, the hepatocytes and the endothelium of the major blood vessels of the grafts retained their donor sex, whereas the entire macrophage system, including the Kupffer cells, was replaced with recipient female cells (identified by their characteristic Barr bodies) within 100 days (7,8) (Fig. 1, middle). These observations attracted considerable attention at the time, primarily because of their implication that liver-based inborn errors of metabolism could be corrected permanently by liver replacement (9,10). This prediction has been met since then in nearly two dozen such heritable diseases (11). Each report of another liver-based metabolic disorder that was corrected by liver replacement added to the illusion that the composite (chimeric) structure of the hepatic allograft was a special feature of this organ.Address reprint requests to: Thomas E. Starzl, M.D., Ph.D., Department of Surgery, 3601 Fifth Avenue, 5C Falk Clinic, University of Pittsburgh, Pittsburgh, PA, 15213. NIH Public Access Author ManuscriptHepatology. Author manuscript; available in PMC 2010 October 26. Published in final edited form as:Hepatology. 1993 June ; 17(6): 1127-1152. NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscript After Intestinal TransplantationThe illusion of uniqueness of the hepatic graft was dispelled in 1991 with the demonstration, first in rat models (12) and then in human beings (13), that all successfully transplanted intestines also were chimeric. The epithelium of the bowel remained that of the donor, but lymphoid, dendritic and other leukocytes of recipient phenotype quickly became the dominant cells in the lamina propria, Peyer's patches and mesenteric nodes. The transformation in experimental animals and in human beings (Fig, 2) was the same whether the bowel was transplanted alone or as a part of a multivisceral gra...

show abstract

“…The usual clinical consequence is fatal cirrhosis within 1 or 2 yr after birth_ However, patients who do not die from liver disease are subject to lethal cardiomyopathy or neuromuscular syndromes (52)(53)(54)(55). Because the enzyme deficiency and consequent amylopectin deposition affect all cells, not just those in the liver, it was surprising to many experts in metabolism when absorption occurred of the amylopectin from the heart and other extrahepatic tissues of five patients with GSD IV 1.3 to 6 yr after liver replacement (Fig_ 10) (56).…”

Section: Direct Evidence Of Systemic Chimerism From Thementioning

confidence: 99%